-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
POINT Biopharma Global Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2020 to Q3 2023.
- POINT Biopharma Global Inc. Operating Income (Loss) for the quarter ending September 30, 2023 was -$29.6M, a 20.3% decline year-over-year.
- POINT Biopharma Global Inc. Operating Income (Loss) for the twelve months ending September 30, 2023 was $108M.
- POINT Biopharma Global Inc. annual Operating Income (Loss) for 2022 was $126M.
- POINT Biopharma Global Inc. annual Operating Income (Loss) for 2021 was -$45.5M, a 247% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)